Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–4 of 4 results
Advanced filters: Author: Marc Bijl Clear advanced filters
  • The authors proffer their response to the question previously posed by Joanne Bargman inNature Clinical Practice Nephrology: “Why are rheumatologists treating lupus nephritis?” They argue that rheumatologists are often the first point of call for patients presenting with systemic lupus erythematosus, and that they are also more adept than nephrologists at assessing certain extrarenal manifestations of the disease. Thus, the rheumatologist is ideally placed to design and monitor treatment, with the aid of a nephrologist.

    • Cees GM Kallenberg
    • Marc Bijl
    Reviews
    Nature Clinical Practice Nephrology
    Volume: 4, P: 60-61
  • Monoclonal antibodies show great promise in treating Covid-19 patients. Here, Maisonnasse, Aldon and colleagues report pre-clinical results for COVA1-18 and demonstrate that it reduces viral infectivity in three animal models with over 95% efficacy in macaques upper respiratory tract.

    • Pauline Maisonnasse
    • Yoann Aldon
    • Roger Le Grand
    ResearchOpen Access
    Nature Communications
    Volume: 12, P: 1-10
  • Systemic lupus erythematosus (SLE) is an autoimmune disease with a strong ethnic and gender bias. In a transancestral genetic association study, Langefeldet al. identify 24 novel regions associated with risk to lupus and propose a cumulative hits hypothesis for loci conferring risk to SLE.

    • Carl D. Langefeld
    • Hannah C. Ainsworth
    • Timothy J. Vyse
    ResearchOpen Access
    Nature Communications
    Volume: 8, P: 1-18
  • Patients with autoimmune inflammatory rheumatic diseases have an impaired immune system that can be exacerbated by medication, making them susceptible to infectious diseases. This article reviews this problem and the potential compounding issue that vaccinating these patients against common infectious diseases is not always safe and effective.

    • Johanna Westra
    • Christien Rondaan
    • Marc Bijl
    Reviews
    Nature Reviews Rheumatology
    Volume: 11, P: 135-145